KN
Kintor Pharmaceutical Limited
KNTPF · OTC
$0.24 +0.00% (+$0.00)
1M +9.09%
Market Cap ¥754.1M
P/E Ratio -
Div. Yield -
ROE 97.23%
Bulios Fair Price
$0.25
4.2% upside
Trenutna cena
$0.24
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KNTPF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
24 /100
Expensive P/S 23.68x
P/B 4.13x
P/E N/A
Growth
0 /100
Declining Book val. growth 50.38%
EPS growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 77.03%
Net margin 612.29%
Op. margin 619.86%
Quality
1 /100
Poor ROIC 65.09%
ROE 97.23%
ROA 57.17%
Debt
40 /100
Moderate Debt/Equity 0.47x
Current ratio 0.43x
Int. coverage -51.36x
Stability
32 /100
Unstable Beta -0.57x
EPS volatility 55.33%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KNTPF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Youzhi Tong
Employees
123
Headquarters
Suzhou
Prihajajoči dogodki
01 APR.
Earnings
Upcoming earnings report